Company / Accounts Receivable
IMMUCELL CORP /DE/ Accounts Receivable History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$3.4M
FY2025
5-year range
$992.4K / $3.8M
FY2021-FY2025
Trend
-9.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Accounts Receivable has fluctuated over the past 10 years, ranging from $346,447 in FY2011 to $4M in FY2024.
Based on SEC 10-K filings.
$3M in FY2025 with a 10-year CAGR of +16.3%.
Improved from $2M to $3M over the past 2 years.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +16.3%
Key checks
Key Insights
- In FY2025, accounts receivable decreased 9.3% year-over-year.
- Peak accounts receivable was recorded in FY2024.
- Lowest accounts receivable in the period was in FY2011.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.4M | -9.3% |
| FY2024 | $3.8M | +72.6% |
| FY2023 | $2.2M | +62.6% |
| FY2017 | $1.3M | +35.4% |
| FY2016 | $992.4K | +31.6% |
| FY2015 | $754.1K | -25.0% |
| FY2014 | $1.0M | +59.2% |
| FY2013 | $631.4K | +10.0% |
| FY2012 | $574.1K | +65.7% |
| FY2011 | $346.4K | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026